Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

Home

/

DNLI

D

Denali Therapeutics Inc. (DNLI)

NMS – Real Time Price. Currency in USD

25.19

+0.50 (2.03%)

Market open: Aug 12, 2026, 10:42 AM EDT

24.65

-0.04 (-0.16%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

331M

108M

Cost of goods sold

-15M

-8M

-17M

-7M

Gross Profit

-15M

-8M

314M

101M

Operating expenses (excl. COGS)

-541M

-494M

-511M

-442M

Operating Income

-555M

-502M

-197M

-341M

Non-operating income, total

43M

79M

52M

15M

Pretax income

-512M

-423M

-145M

-326M

Equity in earnings

0

0

0

0

Taxes

-102K

-68K

-30K

-21K

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-513M

-423M

-145M

-326M

Discontinued operations

0

0

0

0

Net income

-513M

-423M

-145M

-326M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

1.14B-16.7%

1.37B+19.1%

1.15B-21.0%

1.46B

Total current assets

901M

864M

1.06B

1.37B

Total non-current assets

244M

510M

90M

88M

Total liabilities

131M-9.3%

144M+17.5%

123M-70.6%

418M

Total current liabilities

98M

102M

78M

364M

Total non-current liabilities

33M

42M

45M

54M

Total equity

1.01B

1.23B

1.03B

1.04B

Total liabilities & shareholders' equities

1.14B

1.37B

1.15B

1.46B

Total debt

42M-22.2%

54M+4.0%

52M-13.4%

60M

Name

2025

2024

2023

2022

Cash from operating activities

-413M

-348M

-358M

-245M

Cash from investing activities

255M

-89M

249M

-141M

Cash from financing activities

189M

484M

18M

311M

Free cash flow

-422M-16.1%

-364M+2.0%

-371M-41.3%

-263M